Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07013916 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07013916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Recruiting
Start date
June 30, 2025
Completion date
April 1, 2027
Enrollment
72 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mash - metabolic dysfunction-associated steatohepatitis, mash with fibrosis, steatosis of liver